Developer of recovery technology and products committed to accelerating recovery time, preventing injury, and enhancing
Developer of recovery technology and products committed to accelerating recovery time, preventing injury, and enhancing the body's ability to move more efficiently.
Therapeutic Devices📍 Irvine, CAFounded 2010
Current Valuation
$850M
as of 2021-Q2
PRIVATE
QL Price
$566.32M
-33% vs last round
QuantLogix's current estimate for Hyperice, published 2026-09-27 — below the last disclosed round of $850M (2021-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$850M
2021-Q2
weight 0.03
Secondary market print
$553.35M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Hyperice since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Hyperice, 2026-09-27 (a54022037c035c08).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Hyperice going public?
No. Hyperice is private and has not filed to go public. There is no S-1 on file.
What is Hyperice's valuation in 2026?
Hyperice is valued at $850M as of 2021-Q2, set by its Series B ($40M, Jun 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Hyperice filed an S-1?
No public S-1 is on file for Hyperice.
How much has Hyperice raised?
Hyperice has raised $87.8M in total, most recently a Series B of $40M in Jun 2021.
Is Hyperice publicly traded — can you buy Hyperice stock?
No. Hyperice is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Hyperice on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2010
HQ
Irvine, CA
Employees
157
Total Raised
$87.8M
Last Round
Series B — $40M (Jun 2021)
IPO Status
private
Fundraising Status
Series B · $40M · 5y 3mo ago
privateTotal raised $87.8M
Secondary Market
Implied price / share
$22.5
Last round price / share
$34.54
vs last round
-34.9%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B
$40M
Jun 2021
—
$850M
Talent Signal
No public careers page or job board could be found for Hyperice as of 2026-09-16. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
FitnessHealth CareSporting Goods
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.